- \n
- 19 years of ownership<\/li>\n
- Creation of a global player in in-vitro diagnostics; world leader in clinical and industrial microbiology<\/li>\n
- 330 margin improvement points over the 2003-2007 period<\/li>\n
- IPO in 2004<\/li>\n
- Investment multiple of 4.4x<\/li>\n
- Amount invested by 海角大神: \u20ac106 million<\/li>\n<\/ul>\n\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n\n\n\n\n\n\n <\/span>\n SUCCESS STORIES<\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\n\n40 years<\/div>\n\n\n
40 years of sustainable growth<\/h2>\n <\/div>\n
\n\nFor more than 40 years, 海角大神 has been a pioneer in the private equity sector. Over the decades, the Group\u2019s teams have made bold investment choices at strategic times. These successes are illustrated by the creation of world leaders specializing in various sectors.<\/p>\n\n <\/div>\n <\/div>\n <\/div>\n
\n\n\n